Back

Proarrhythmic interaction of NaV1.8 and CaMKII in human heart failure

25 May 2019 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Poster Session 3 - Basic Science - Cardiomyopathies 1 Arrhythmias HFA Premium Access Heart Failure 2019

About the speaker

Photo
Mr Petros Tirilomis

University Medical Centre of Gottingen (UMG), Goettingen (Germany)

8 More presentations in this session

Presentation thumbnail
Basic Science - Cardiomyopathies - Poster Discussant - 10:00-11:00.
Presentation thumbnail
A novel peptide agonist of galanin receptors reduces doxorubicin-induced heart failure in rats
Mr R. Lyubimov (Moscow, RU)
Abstract Slides
Presentation thumbnail
Impact of glutathione S-transferase M1, T1 and P1 gene polymorphisms on the chronic heart failure
Doctor N. Jankovic (Belgrade, RS)
Abstract
Presentation thumbnail
Murine Experimental Autoimmune Myocarditis (EAM) is associated with LV hypertrophy but not with reduced LV systolic function
Doctor M. Mirna (Salzburg, AT)
Abstract Slides
Presentation thumbnail
Role of innate immune mediators in cardiac damage induced by Doxorubicin in vitro
Doctor J. Gambardella (Napoly, IT)
Abstract

Access the full session

Session thumbnail
Poster Session 3 - Basic Science - Cardiomyopathies 1

The Event

Event poster

Heart Failure 2019

25 May - 28 May 2019
You may be interested in
thumbnail
Congress Session
Risk stratification
thumbnail
Congress Session
Malignant arrhythmias
thumbnail
Congress Session
Novel arrhythmia treatments

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources